S2Medical AB (publ) (FRA:S21)

Market Cap	1.02M +30.8%
Revenue (ttm)	1.39M +40.8%
Net Income	-247.47K
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.0004
Previous Close	0.0005
Day's Range	0.0004 - 0.0004
52-Week Range	0.0001 - 0.0085
Beta	n/a
RSI	54.84
Earnings Date	Feb 20, 2026

About S2Medical AB

S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and Epiprotect, a technology designed to protect and support wound healing by creating an environment for tissue recovery. It also provides Symbiovance, a...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2013
• Employees: 7
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: S21

Financial Performance

Financial numbers in SEK